The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...

Novo Nordisk launches new CagriSema trial; Pfizer leads drugmaker dialogue with White House; FDA halts Gilead’s HIV treatment ...

Merck’s Enflonsia receives US FDA approval for prevention of RSV lower respiratory tract disease in infants born during or entering their first RSV season: Rahway, New Jersey We ...

With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...

The FDA approved the monoclonal antibody clesrovimab-cfor for the prevention of respiratory syncytial virus lower respiratory ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.

Health Secretary Robert F. Kennedy Jr. removed members of an advisory vaccine panel at the Centers for Disease Control and ...

U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr., abruptly removes all 17 sitting members of the CDC’s ...

In a striking move on Monday, Robert F. Kennedy, Jr., secretary of the U.S. Department Health and Human Services, announced ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Merck announced yesterday that the US Food and Drug Administration (FDA) has approved its monoclonal antibody vaccine ...

Approval of Enflonsia was based on data from the Phase IIb/III CLEVER trial, which showed a 60.5% reduction in medically ...